Table 1.
Association of ALG3 expression with clinicopathological characteristics in 90 patients of breast cancer.
| No. of patients (n=90) | ALG3 expression | P value | ||
|---|---|---|---|---|
| Low no. (%) | High no. (%) | |||
| Characteristics | ||||
| Age (years) | >0.05 | |||
| <50 | 48 | 22 (45.80%) | 26 (54.20%) | |
| ≥50 | 42 | 20 (47.62%) | 22 (52.38%) | |
| Normal breast | 90 | 76 (84.44%) | 14 (15.56%) | <0.05 |
| Cancer tissues | 90 | 16 (51.11%) | 74 (48.89%) | |
| FIGO stage | <0.05 | |||
| I/II | 52 | 12 (23.08%) | 40 (76.92%) | |
| III/IV | 38 | 4 (10.53%) | 34 (89.47%) | |
| Grade | ||||
| 1 | 42 | 10 (23.80%) | 32 (76.20%) | |
| 2 | 28 | 4 (14.29%) | 24 (85.71%) | |
| 3 | 20 | 2 (10.00%) | 18 (90.00%) | |
| Grade 2–3 versus 1 | <0.05 | |||